User Reviews for Erleada
Condition | Avg. Rating | Reviews | Compare | |
---|---|---|---|---|
Prostate Cancer | 8.0 | 2 reviews | 55 medications |
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
For Prostate Cancer: “After two months on Erleada my PSA is lower. Taking drug four times is a challenge. So far side effects are minor.”
This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
More about Erleada (apalutamide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: antiandrogens
- FDA Approval History
For Prostate Cancer: “77 years old, prostatectomy 16 years ago, PSA began doubling every month in 2017, Stage 4 PCa diagnosed, PSA surged to >50, began and still on Firmagon. After beginning Erleada at 4 pills with my evening meal, my PSA dropped roughly 80% every month thereafter. It's been <0.01 for months now. The only side effect I've noticed is physical weakness when I work out or play hard (I'm a very active athlete). My docs attribute that to my very low (single digit on the 300-800 scale) testosterone, not to the med itself. My poor balance, muscle loss, and some muscle and joint aches and pains are probably due respectively and primarily to 25 years with Meniere's disease, closed gyms plus no T, and prior injuries or current overuse. I'm extremely pleased with Erleada, and it gives my oncologist a proven (in my case) fallback position as he tweaks my medication protocol to keep confusing and thwarting my widespread cancer.”